Renato Tamaro Net Worth

The estimated Net Worth of Renato Tamaro is at least $1.9 Milione dollars as of 16 May 2024. Renato Tamaro owns over 1,154 units of Steris Plc stock worth over $1,895,572 and over the last 6 years he sold STE stock worth over $0. In addition, he makes $0 as Vice President and Corporate Treasurer at Steris Plc.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

Renato Tamaro STE stock SEC Form 4 insiders trading

Renato has made over 3 trades of the Steris Plc stock since 2019, according to the Form 4 filled with the SEC. Most recently he exercised 1,154 units of STE stock worth $131,810 on 16 May 2024.

The largest trade he's ever made was exercising 2,065 units of Steris Plc stock on 14 August 2019 worth over $175,979. On average, Renato trades about 246 units every 91 days since 2018. As of 16 May 2024 he still owns at least 7,831 units of Steris Plc stock.

You can see the complete history of Renato Tamaro stock trades at the bottom of the page.

Renato Tamaro biography

Renato Tamaro is the Vice President and Corporate Treasurer at Steris Plc.

How old is Renato Tamaro?

Renato Tamaro is 51, he's been the Vice President and Corporate Treasurer of Steris Plc since 2017. There are 15 older and 5 younger executives at Steris Plc. The oldest executive at Steris Plc is David Lewis, 76, who is the Independent Director.

What's Renato Tamaro's mailing address?

Renato's mailing address filed with the SEC is C/O 70 SIR JOHN ROGERSON'S QUAY, , DUBLIN, L2, 2.

Insiders trading at Steris Plc

Over the last 9 years, insiders at Steris Plc have traded over $157,726,045 worth of Steris Plc stock. The most active insiders traders include Richard Martin Steeves, Walter M Jr Rosebrough e John P Wareham. On average, Steris Plc executives and independent directors trade stock every 19 days with the average trade being worth of $3,374,074. The most recent stock trade was executed by Christopher S Holland on 8 August 2024, trading 473 units of STE stock currently worth $113,369.

What does Steris Plc do?

steris is a leading provider of infection prevention and procedural surgical products and services, focused primarily on healthcare, pharmaceutical, research and medical device customers. our mission is to provide a healthier today and a safer tomorrow through knowledgeable people and innovative infection prevention, decontamination and health science technologies, products and services. while the corporation was founded as innovative medical technologies in 1985 and renamed steris in 1987, our history dates back to 1894 with the founding of american sterilizer company, a long-time, global leading innovator of sterilization products. today, through a series of strategic acquisitions and continual innovation of new products, steris holds one of the broadest portfolios of products in the industry. it stands at the forefront of efforts to prevent infection and contamination in healthcare, pharmaceutical and medical device environments.

Complete history of Renato Tamaro stock trades at Steris Plc

Steris Plc executives and stock owners

Steris Plc executives and other stock owners filed with the SEC include:

• Walter Rosebrough,
  President, Chief Executive Officer, Director
• Walter M. Rosebrough Jr.,
  CEO Emeritus & Sr. Advisor
• Michael Tokich,
  Chief Financial Officer, Senior Vice President
• Daniel Carestio,
  Chief Operating Officer, Senior Vice President
• J. Adam Zangerle,
  Senior Vice President, General Counsel, Secretary
• Daniel A. Carestio,
  Pres, CEO & Director
• Cary Majors,
  Vice President - North America Commercial Operations
• Michael J. Tokich,
  Sr. VP & CFO
• John Adam Zangerle,
  Sr. VP, Gen. Counsel, Sec.
• Cary L. Majors,
  Sr. VP of North America Commercial Operations
• Mohsen Sohi,
  Independent Chairman of the Board
• David Lewis,
  Independent Director
• Jacqueline Kosecoff,
  Independent Director
• Richard Steeves,
  Independent Director
• Richard Breeden,
  Independent Director
• Loyal Wilson,
  Independent Director
• Nirav Shah,
  Independent Director
• Cynthia Feldmann,
  Independent Director
• Duncan Nichol,
  Independent Director
• Michael Wood,
  Independent Director
• Christopher Holland,
  Director
• Renato Tamaro,
  Vice President and Corporate Treasurer
• Renato G. Tamaro,
  VP & Corp. Treasurer
• Julia K. Madsen,
  Sr. VP of Life Sciences
• Mary Clare Fraser,
  VP & Chief HR Officer
• Julie Winter,
  VP of Investor Relations & Corp. Communications
• Karen L. Burton,
  Chief Accounting Officer, VP & Controller
• Esther M. Alegria,
  Director
• Kathleen Bardwell,
  Sr.V. P. & C.C.O.
• Sudhir K Pahwa,
  Sr. V.P., IPT
• Suzanne V Forsythe,
  V. P. - Human Resources
• Gulam Amjad Khan,
  Sr. V.P., Procedural Solutions
• Adrian Vincent Coward,
  Sr. V. P., Healthcare Services
• John P Wareham,
  Director
• Michiel De Zwaan,
  V.P., Human Resources & CHRO
• Kevin M Mcmullen,
  Director
• Mary Clare Fraser,
  SVP & Chief HRO
• Julia Madsen,
  Senior VP, Life Sciences
• Paul Edward Martin,
  Director
• Andrew Xilas,
  SVP and GM, Dental
• Kenneth E Kohler,
  SVP & GM, AST
• Karen L Burton,
  VP & CAO